Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

imtrade australia pty ltd - trifluralin; prosulfocarb - emulsifiable concentrate - trifluralin anilide/aniline-dinitro active 250.0 g/l; prosulfocarb carbamate-thiocarbamate active 670.0 g/l - herbicide

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

imtrade australia pty ltd - diazinon - emulsifiable concentrate - diazinon organophosphorus active 800.0 g/l - insecticide

Australia - English - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - insulin glargine, quantity: 32.74 mg - injection, solution - excipient ingredients: metacresol; zinc chloride; glycerol; sodium hydroxide; hydrochloric acid; water for injections - treatment of diabetes mellitus in adults

Singapore - English - HSA (Health Sciences Authority)

ppm medical pte ltd - general hospital - the forceps are a sterile, single use device intended to grasp tissue/ surgical gauze and sponges/ organs etc. the forceps are designed (classical design) for a specific anatomical type or anatomical area, by decision of surgeon/ clinician.

Australia - English - Department of Health (Therapeutic Goods Administration)

australia biotech pty ltd - ct943 - instrument/analyser ivds - this automated nucleic acid extractor uses magnetic rods on magnetic rod racks to transfer magnetic beads bound with nucleic acid to different wells, and mixes liquid at fast speed and repeatedly with magnetic rod sleeves outside magnetic rods. the liquid is mixed evenly. and after cell lysis, nucleic acid binding, washing and elution, highly purified dna/rna nucleic acid molecules is finally achieved. the automated nucleic acid extraction system is a high-tech product that uses advanced magnetic bead separation technology. it has the advantages of high automation, fast extraction speed, stable results, and easy operation. all separation and purification procedures are completed in 96 well plates and it completely gets rid of the steps of au1001s automated nucleic acid extraction system manual 8 centrifugation and filtration that are necessary in conventional extraction and purification. the system can complete fast extraction and purification process from 1 to 32 samples, including but not limited to blood, tissue, cells, swab, virus and other clinical or forensic samples. the extracted high quality dna/rna is ready for use in highly sensitive downstream analysis, such as qpcr, clinical molecular diagnostic, analysis of gene expression, gene analysis, forensic and infectious disease research etc. the purified nucleic acid can be applied directly for the next enzyme cleavage, identification as well as disease diagnosis and treatment etc. over 100 kinds of extraction kits for use with this instrument to maximize its application and minimize its costs.

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

cropsure pty ltd - abamectin - emulsifiable concentrate - abamectin anthelmintic active 36.0 g/l - insecticide

New Zealand - English - Medsafe (Medicines Safety Authority)

novartis new zealand ltd - canakinumab 150 mg/ml - solution for injection - 150 mg/ml - active: canakinumab 150 mg/ml excipient: histidine mannitol polysorbate 80 water for injection - ilaris is indicated for the treatment of cryopyrin-associated periodic syndromes (caps), in adults and children aged 2 years and older including: · familial cold autoinflammatory syndrome (fcas) /familial cold urticaria (fcu) · muckle-wells syndrome (mws) · neonatal-onset multisystem inflammatory disease (nomid) / chronic infantile neurological, cutaneous, articular syndrome (cinca).

Australia - English - Department of Health (Therapeutic Goods Administration)

moderna australia pty ltd - elasomeran, quantity: 0.05 mg/ml; davesomeran, quantity: 0.05 mg/ml - injection, suspension - excipient ingredients: 1,2-dimyristoyl-rac-glycero-3-methoxypolyethylene glycol-2000; distearoylphosphatidylcholine; heptadecan-9-yl 8-[2-hydroxyethyl-(6-oxo-6-undecoxyhexyl)amino]octanoate; sucrose; trometamol; cholesterol; trometamol hydrochloride; sodium acetate trihydrate; water for injections; glacial acetic acid - spikevax bivalent original/omicron ba.4-5 (elasomeran/davesomeran) covid-19 vaccine is indicated for:,as a booster dose for active immunisation to prevent coronavirus disease 2019 (covid-19) caused by sars-cov-2 in individuals 12 years of age and older who have previously received at least a primary vaccination course against covid-19.,the use of this vaccine should be in accordance with official recommendations.

Australia - English - Department of Health (Therapeutic Goods Administration)

moderna australia pty ltd - davesomeran, quantity: 0.05 mg/ml; elasomeran, quantity: 0.05 mg/ml - injection, suspension - excipient ingredients: water for injections; cholesterol; glacial acetic acid; heptadecan-9-yl 8-[2-hydroxyethyl-(6-oxo-6-undecoxyhexyl)amino]octanoate; trometamol; sucrose; distearoylphosphatidylcholine; sodium acetate trihydrate; 1,2-dimyristoyl-rac-glycero-3-methoxypolyethylene glycol-2000; trometamol hydrochloride - spikevax bivalent original/omicron ba.4-5 (elasomeran/davesomeran) covid-19 vaccine is indicated for:,as a booster dose for active immunisation to prevent coronavirus disease 2019 (covid-19) caused by sars-cov-2 in individuals 12 years of age and older who have previously received at least a primary vaccination course against covid-19.,the use of this vaccine should be in accordance with official recommendations.

Australia - English - Department of Health (Therapeutic Goods Administration)

moderna australia pty ltd - elasomeran, quantity: 0.05 mg/ml; davesomeran, quantity: 0.05 mg/ml - injection, suspension - excipient ingredients: 1,2-dimyristoyl-rac-glycero-3-methoxypolyethylene glycol-2000; distearoylphosphatidylcholine; heptadecan-9-yl 8-[2-hydroxyethyl-(6-oxo-6-undecoxyhexyl)amino]octanoate; sucrose; trometamol; cholesterol; trometamol hydrochloride; sodium acetate trihydrate; water for injections; glacial acetic acid - spikevax bivalent original/omicron ba.4-5 (elasomeran/davesomeran) covid-19 vaccine is indicated for:,as a booster dose for active immunisation to prevent coronavirus disease 2019 (covid-19) caused by sars-cov-2 in individuals 12 years of age and older who have previously received at least a primary vaccination course against covid-19.,the use of this vaccine should be in accordance with official recommendations.